Key points from the 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Professor Marco Metra was the co-chairman of the update to the ESC Heart Failure guidelines of 2021. The update incorporate data from nearly a dozen new clinical trials published since 2021, including EMPEROR-Preserved, DELIVER, STRONG-HF, IRONMAN, and more. The new guidelines include new recommendations related to SGLT2 inhibitor use in patients with heart failure with mildly reduced ejection fraction or with preserved ejection fraction as well as updated guidance surrounding management of comorbidities.
You can access the document on the ESC website by clicking here.